China Grand Pharmaceutical and Healthcare Holdings Limited provided unaudited earnings guidance for the six months ended June 30, 2021. For the six months, it is expected that the consolidated net profit attributable to owners of the Company recorded an increase of not less than 50% as compared to that of the six months ended 30 June 2020. The unaudited consolidated net profit attributable to owners of the Company for the six months ended 30 June 2020 amounted to approximately HKD 718,509,000.